Additive manufacturing particularly three-dimensional (3D) and emerging four-dimensional (4D) printing, is increasingly recognized as a transformative approach for the future of pharmaceutical manufacturing. Conventional pharmaceutical production relies on centralized, large-scale batch processes designed for standardized medicines, which limits flexibility for individualized therapies. In contrast, 3D printing enables the fabrication of drug products with precise control over geometry, internal structure, dose, and spatial distribution of active pharmaceutical ingredients, supporting the growing paradigm of personalized medicine. Several pharmaceutical printing technologies including fused deposition modeling, semi-solid extrusion, inkjet printing, and stereolithography have been investigated for the production of tablets, films, implants, and drug eluting devices. These techniques allow the design of complex dosage forms, multi-drug polypills, and tailored drug release profiles. Research in this area has also demonstrated the feasibility of printable pharmaceutical formulations and advanced drug delivery systems, highlighting the potential of additive manufacturing to customize medicines while maintaining appropriate pharmaceutical properties. As these technologies mature, pharmaceutical manufacturing may gradually shift toward more flexible and decentralized environments, including hospital pharmacies. In this evolving model, pharmacists will play an increasingly important role in digital formulation design, on -demand manufacturing, quality assurance, and regulatory oversight of printed medicines.

Chair:
- Mathew Cherian, VP of Operations and R&D, ReVive Biotechnology; Member IPS ExCo, USA

Co-moderator:
- Qurrotul Aini Shodiquna, IPS Liaison at FIP ECPG, Indonesia

Panellist:
- Erem Bilensoy, Professor Faculty of Pharmacy, Hacettepe University, Turkey

This webinar explores the impact of medicines shortages and examples of legislative instruments from around the globe to address the issue. It highlights the potential for the use of Real-World Data to manage prevent medicine shortages. It also identifies and describes how to improve visibility of inventory across the pharmaceutical supply chain, different data collection strategies used to achieve supply chain visibility.

Chair:
- Rob Moss, FIP Vice President and Co-Chair of the FIP Technology Advisory Group, International Pharmaceutical Federation (FIP), The Netherlands

Panellists:
- Noelle Horan, Medicines Information Pharmacist, Irish Pharmacy Union, Ireland
- Matthew Christian, Director, Digital Product Engineering and Pilots, United States Pharmacopeia (USP), USA
- Esteban Zavaleta, Director of Pharmacy, Hospital Clinica Biblica, Costa Rica

La salud avanza a un ritmo acelerado en esta era de transformación digital e inteligencia artificial. Las innovaciones en medicina personalizada abren un panorama prometedor para mejorar diagnósticos, tratamientos y la calidad de vida de las personas. Sin embargo, estos avances también generan desafíos significativos en materia regulatoria y de acceso. En este webinar se abordará cómo impulsar la innovación desde una perspectiva de equidad, garantizando que los beneficios de los nuevos medicamentos, tecnologías e insumos médicos lleguen efectivamente a quienes más los necesitan. Asimismo, se analizará cómo los marcos regulatorios deben adaptarse de manera ágil y responsable para acompañar el ritmo del desarrollo científico, promoviendo tanto la seguridad como la accesibilidad. El encuentro buscará ofrecer una mirada integral sobre las oportunidades y retos que la innovación representa para la salud pública en un contexto global en constante evolución.

Moderador:
- Jorge Schlottke, Exco Member, FIP-CPS, Argentina

Co-moderadora:
- Carolina Martinez-Berganza, Member, FIP Regulators Advisory Group, España

Panelistas:
- Alejandra Gomez, President, Confederación Farmaceutica Argentina, Argentina
- Carlos Fernandez Moriano, Consejo General de Colegios de Farmacéuticos, España
- Talita Ferreira, CEO, Leguis Consultoria, Brasil

EUFEPS is pleased to announce that the 2026 Annual Meeting will be held in Naples, Italy, from May 27th to 29th, 2026. This year, the meeting will be organized in collaboration with SITELF (Italian Society of Pharmaceutical Technology and Legislation), further strengthening the collaboration between leading pharmaceutical scientists across Europe.

The 13th IPCRG World Conference and 1st North African Interdisciplinary Respiratory Forum is a great opportunity to meet leaders in primary care, make new contacts and spend valuable time in an open and friendly atmosphere with other people passionate about primary respiratory care. 

The Journal of Pharmaceutical Policy and Practice (JoPPP) was established in 2008 with the mission to promote pharmaceutical policy and practice globally. The journal is published in the United Kingdom, indexed in Scopus and PubMed Central, and managed by a distinguished international editorial board. Based on its growing body of research articles, presentations, and best practices, JoPPP will hold the “5th JOPPP IMPACT MONGOLIA - 2026” conference in collaboration with Etugen University on November 11–13, 2026.

Join us for the world’s first LGBTQIA+-focused pharmacy conference, proudly endorsed by the International Pharmaceutical Federation (FIP). This landmark three-day event brings together LGBTQIA+ pharmacists, students, educators, researchers and allies to build a more inclusive and culturally safe future for pharmacy practice.